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BackgroundInfections may be associated with exacerbation of allergic and
autoimmune diseases. Paradoxically, epidemiological and experimental data have
shown that some microorganisms can also prevent these pathologies. This
observation is at the origin of the hygiene hypothesis according to which the decline
of infections in western countries is at the origin of the increased incidence of both
Th1-mediated autoimmune diseases and Th2-mediated allergic diseases over the last
decades. We have tested whether Toll-like receptor (TLR) stimulation can
recapitulate the protective effect of infectious agents on allergy and autoimmunity.
Methods and Findings Here, we performed a systematic study of the disease-
modifying effects of a set of natural or synthetic TLR agonists using two experimental
models, ovalbumin (OVA)-induced asthma and spontaneous autoimmune diabetes,
presenting the same genetic background of the non obese diabetic mouse (NOD) that
is highly susceptible to both pathologies. In the same models, we also investigated
the effect of probiotics. Additionally, we examined the effect of the genetic
invalidation of MyD88 on the development of allergic asthma and spontaneous
diabetes. We demonstrate that multiple TLR agonists prevent from both allergy and
autoimmunity when administered parenterally. Probiotics which stimulate TLRs also
protect from these two diseases. The physiological relevance of these findings is
further suggested by the major acceleration of OVA-induced asthma in MyD88
invalidated mice. Our results strongly indicate that the TLR-mediated effects involve
immunoregulatory cytokines such as interleukin (IL)-10 and transforming growth
factor (TGF)-β and different subsets of regulatory T cells, notably
CD4+CD25+FoxP3+ T cells for TLR4 agonists and NKT cells for TLR3 agonists.
Conclusions/Significance These observations demonstrate that systemic
administration of TLR ligands can suppress both allergic and autoimmune responses.
They provide a plausible explanation for the hygiene hypothesis. They also open new
therapeutic perspectives for the prevention of these pathologies.
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